Details for Patent: 5,629,425
✉ Email this page to a colleague
Summary for Patent: 5,629,425
Title: | Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thi ophene |
Abstract: | The present invention is directed to chemical processes for preparing 2-aryl-6-hydroxy-3-[4-(2-aminoethoxy)benzoyl]benzo[b]thiophenes. The present invention is also directed to crystalline solvates and a non-solvated crystalline form of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thi ophene hydrochloride, as well as processes for their preparation. |
Inventor(s): | LaBell; Elizabeth S. (Lafayette, IN), McGill; John M. (Lafayette, IN), Miller; Randal S. (Lafayette, IN) |
Assignee: | Eli Lilly and Company (Indianapolis, IN) |
Application Number: | 08/308,325 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 5,629,425
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,629,425
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 754 | ⤷ Try a Trial | |||
African Regional IP Organization (ARIPO) | 9700938 | ⤷ Try a Trial | |||
Austria | 407988 | ⤷ Try a Trial | |||
Austria | 502957 | ⤷ Try a Trial | |||
Austria | 504859 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |